![]() All other trademarks are trademarks of their respective owners or holders. Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Aero, Berchtold, BIO4, Clarity, CORE, Cranial iD, CranialMap, CranialMask, DirectInject, DuraMatrix, πdrive, ES2, Everest, Excelsior, FlowGate, Gateway, HydroSet, iSuite, iVAS, LITe, Maestro, Malis, MEDPOR, Mesa, MultiGen, Nano, Neuroform EZ, OASYS, SL-10, SDC3, Serengeti, Serrato, SILVERGlide, Sonopet, Spetzler, SpineJack, SpineMap, SpineMask, Stentriever, Streamline, Stryker, Stryker iD, Stryker NAV3i, Switchpoint Infinity, Synchro, Target, Target XL, TransForm, Trevo, Tritanium, Universal Neuro, Venom, Vitoss, VLIFT, Wingspan, Xia, XT-17, XT-27. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. A healthcare professional must always refer to the package insert, product label and/or instructions for use before using any Stryker product. The information presented is intended to demonstrate the breadth of Stryker product offerings. ![]() Stryker does not dispense medical advice and recommends that healthcare professionals be trained in the use of any particular product before using it in a procedure/surgery. Vitoss BiModal Bioactive Bone Graft SubstituteĪ healthcare professional must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Tritanium TL Curved Posterior Lumbar Cage SpineMap 3D Navigation Software - SpineMask Tracker - Stryker NAV3i Platform LITe Pedicle Based Retractor (PBR) System Aero-AL Anterior Lumbar Interbody and Fixation SystemĪero-C Anterior Cervical Interbody and Fixation SystemĬranialMap 3.0 Navigation Software - CranialMask Tracker - Stryker NAV3i PlatformĮVEREST Minimall Invasive XT Spinal System
0 Comments
Leave a Reply. |